John Libbey Eurotext

Bulletin du Cancer

MENU

Radiofrequency ablation in the treatment of liver and lung tumors Volume 96, issue 11, novembre 2009

Figures

See all figures

Authors
Départements de radiologie, Institut Bergonié, Centre régional de lutte contre le cancer, 229, cours de l’Argonne, 33076 Bordeaux cedex, France, Département d’oncologie digestive, Institut Bergonié, Centre régional de lutte contre le cancer, 229, cours de l’Argonne, 33076 Bordeaux cedex, France, Service de médecine nucléaire, Institut Bergonié, Centre régional de lutte contre le cancer, 229, cours de l’Argonne, 33076 Bordeaux cedex, France, Département d’oncologie médicale, Institut Bergonié, Centre régional de lutte contre le cancer, 229, cours de l’Argonne, 33076 Bordeaux cedex, France, Service de chirurgie, Institut Bergonié, Centre régional de lutte contre le cancer, 229, cours de l’Argonne, 33076 Bordeaux cedex, France, Service d’oncologie médicale, hôpital Saint-André, 1, rue Jean-Burguet, 33075 Bordeaux cedex, France

Radiofrequency (RF) ablation is a technique of thermotherapy which emerged over the last fifteen years in the field of oncology. RF directed toward a specific tumor mass is known to be very effective (over 90%) for treating tumors less than 2.5 cm. RF is used for patients with early-stage lung or liver cancers who are not surgical candidates, With improvements in systemic therapy, increasing interest in the use of local therapy for metastases has arisen. Eradication of residual metastases via local therapies has a sense in patients with stabilized disease. Nonsurgical alternative like RF has become popular because it is less invasive than surgery and has demonstrated great efficiency. Nevertheless prospective randomized trials to compare RF with surgery are difficult to achieve, prospective studies are needed to better evaluate the technique.